EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Future Treatment Options for Managing Primary Sclerosing Cholangitis and Cholestatic Pruritus

Taranika Sarkar Das, Raj Vuppalanchi

Clinics in Liver Disease · 2025

DOI: 10.1016/j.cld.2025.06.010 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Clinics in Liver Disease, 2025. Verfasst von Taranika Sarkar Das und 1 weiteren Autor:innen. Beteiligte Einrichtung: The Brooklyn Hospital Center, 121 DeKalb Avenue, Brooklyn, NY 11201, USA; NYU Langone Health, 550 1st Avenue, New York, NY 10016, USA. Hauptthemen laut MEDLINE: Cholangitis, Sclerosing, Pruritus, Cholestasis, Cholagogues and Choleretics. Die Arbeit nennt 112 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Primary sclerosing cholangitis (PSC) is a rare disease, autoimmune in nature, characterized by biliary strictures, chronic cholestasis, and progressive liver dysfunction. While its pathophysiology differs from primary biliary cholangitis (PBC), therapeutic targets still focus on bile acid regulation. PSC currently has no approved therapies, although several novel agents are under investigation. Cholestatic pruritus, a significant symptom in PSC and PBC, is now recognized as an approvable indication, with emerging therapies showing promise. This article highlights the investigational pipeline for PSC and cholestatic itch.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cholangitis, SclerosingPruritusCholestasisCholagogues and CholereticsUrsodeoxycholic AcidHumansPropionatesChalcones

Stichwörter der Autor:innen

Alkaline phosphataseCholestatic liver diseaseFarnesoid receptor agonistsNovel therapeuticsPeroxisome proliferator-activated receptor agonists

Substanzen

Cholagogues and CholereticsUrsodeoxycholic Acid2-(2,6-dimethyl-4-(3-(4-(methylthio)phenyl)-3-oxo-1-propenyl)phenoxyl)-2-methylpropanoic acidPropionatesChalcones

Autor:innen und Institutionen

  • The Brooklyn Hospital Center, 121 DeKalb Avenue, Brooklyn, NY 11201, USA; NYU Langone Health, 550 1st Avenue, New York, NY 10016, USA.
  • Division of Gastroenterology and Hepatology, Indiana University School of Medicine, 702 Rotary Circle, Suite 225, Indianapolis, IN 46202, USA. Electronic address: rvuppala@iu.edu.

Zitieren

APA

Das, T. S., & Vuppalanchi, R. (2025). Future Treatment Options for Managing Primary Sclerosing Cholangitis and Cholestatic Pruritus. Clinics in Liver Disease. https://doi.org/10.1016/j.cld.2025.06.010

Vancouver

Das TS, Vuppalanchi R. Future Treatment Options for Managing Primary Sclerosing Cholangitis and Cholestatic Pruritus. Clinics in Liver Disease. 2025. doi:10.1016/j.cld.2025.06.010

BibTeX
@article{Das2025,
  author = {Das, Taranika Sarkar and Vuppalanchi, Raj},
  title = {Future Treatment Options for Managing Primary Sclerosing Cholangitis and Cholestatic Pruritus},
  journal = {Clinics in Liver Disease},
  year = {2025},
  doi = {10.1016/j.cld.2025.06.010}
}
Kostenlos starten →